Pacer Advisors’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Pacer Advisors's KITE Position: Q4 2017 in Review
Pacer Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 936 shares — an estimated $168K sold.
Pacer Advisors first reported a position in KITE in Q1 2017 and held it in 3 quarters. The position peaked at $607K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Pacer Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Pacer Advisors sold 936 Kite Pharma, Inc. shares in Q4 2017, an estimated $168K.
- Pacer Advisors first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 3 quarters.
- Pacer Advisors's Kite Pharma, Inc. position peaked at $607K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.